Acta rheumatologica - Institut za reumatologiju

5) Giannini EH. Brewer E.J. Poor correlation between the erytrocyte sedimentation rate and
clinical activity in juvenile rheumatoid arthritis. Clin.Rheumatol. 1987; 6: 197 - 201.
6)Volanakis JE. Acute phase proteins in rheumatic disease in: Mc Carty D.J.,Koopman W.J
eds. Arthritis and allied conditions,12-th edition, Lea & Febiger, Philadelphia-London 1993.
469 - 477.
7) Hussein A, Stein J, Ehrich JFF. C-reactive protein in the assessment of disease activity in
juvenile rheumatoid arthritis and juvenile spondylarthritis. Scand J Rheumatol 1987;16:101-
105.
8) Yazici H,Yurdakul S, Hamuryudan V,Fresko I. Behcet's syndrome in: Hochberg MC,
Silman AJ, Smolen JS,Weinblatt ME,Weisman MH editors, Rheumatology. Mosby.
Elsevier limited 2003. Edinburgh-London-New York-Oxford-Philadelphia-St Louis-
Sydney-Toronto. pp 1665-1669.
9) Benz EJ. Hemoglobinopathies In: Harison's principles of internal medicine. Mc Graw-
Hill 2001. New York, San Francisco, Washington DC, Auckland, Bogota, Caracas. 666-671
10) Ilovite NT. Current treatment of Juvenile Rheumatoid Arthritis.Pediatrics
2002;109(1):109-115.
11) West SG, Kotzin BL, Sarcoidosis. in: Hochberg MC, Silman AJ, Smolen JS,Weinblatt
ME,Weisman MH editors, Rheumatology. Mosby. Elsevier limited 2003. Edinburgh-
London- New York-Oxford-Philadelphia-St Louis-Sydney-Toronto. 1735-1745.
12)Isselbacher LJ, Epstein A. Diverticular, vascular and other disorders of theintestine and
peritoneum in: Braunwald E, Fauci AS,Kasper D, Hauser SL, Longo DL, Jameson JL
editors In: Harison's principles of internal medicine. Mc Graw-Hill 2001.New York, San
Francisco, Washington DC,Auckland, Bogota, Caracas.1695-1704.
13) Cassidy JT. Juvenile rheumatoid arthritis in: Kelley W.N, Harris E.D., Ruddy S., Sledge
C.B. eds. Textbook of Rheumatology.W.B.Saunders comp. Philadelphia-London-Toronto-
Montreal.Sydney-Tokyo 1997. 1207 – 1224.
14) Vojnović J. Etio-patogenetske dileme sistemske forme juvenilnog idiopatskog artritisa.
Acta rheum Belgrad 2005: 35:(1-2),..... u štampi
15) Villanueva J,Lee S, Giannini EH,Graham T, Passo MH, Filipovich A,Grom AA. Natural
killer cell dysfunction is a distinguishing feature of systemic onset juvenole rheumatoid
arthritis and macrophage activation syndrome. Arthritis Res Ther 2004;7(1):30-37.
16) Ravelli A, Carcia MC,Buratti S,Temporini F, Martini A. Mehotrexate as a possible
trigger of macrophage activation syndrome in systemc juvenle idiopathic arthritis. J
Rheumatol 2001;28:865-7.
17) Ramanan AV, Schneider R. Macrophage activation syndrome following initiation of
etanercept in a child with systemic onset juvenile rheumatoid arthritis. J Rheumatol
2003;30:401-3.